Insider

David Altshuler Insider Trading Activity

Every SEC Form 4 transaction reported by David Altshuler, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is David Altshuler buying or selling?

David Altshuler reported 0 open-market buys ($0) and 71 sells ($80.7M) across 71 Form 4 filings at 1 company — a net selling position of $80.7M.

Source: SEC EDGAR Form 4

What stands out

  • All 71 of David Altshuler's Form 4 filings are for one company, VERTEX PHARMACEUTICALS INC / MA (VRTX).
  • The most recent Form 4 was accepted on May 19, 2025 (16 months ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of May 19, 2025)

Total Form 4 filings
71
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (71)
$80.7M

Insider sentiment

Net selling

Net insider flow of $80.7M in net selling, filed between Jan 17, 2018 – May 19, 2025.

Companies David Altshuler files for

#CompanyForm 4 filings
1VRTXVERTEX PHARMACEUTICALS INC / MA71

Recent David Altshuler transactions

DateTickerRoleTypeSharesValueFiling
May 19, 2025VRTXEVP, Chief Scientific OfficerSale52$22.1KSEC ↗
Mar 17, 2025VRTXEVP, Chief Scientific OfficerSale3.2K$1.6MSEC ↗
Mar 12, 2025VRTXEVP, Chief Scientific OfficerSale3.2K$1.6MSEC ↗
Mar 5, 2025VRTXEVP, Chief Scientific OfficerSale3.2K$1.6MSEC ↗
Feb 28, 2025VRTXEVP, Chief Scientific OfficerSale1.3K$610.6KSEC ↗
Feb 26, 2025VRTXEVP, Chief Scientific OfficerSale848$407.8KSEC ↗
Feb 24, 2025VRTXEVP, Chief Scientific OfficerSale1.1K$533.3KSEC ↗
Nov 19, 2024VRTXEVP, Chief Scientific OfficerSale15$7.2KSEC ↗
May 17, 2024VRTXEVP, Chief Scientific OfficerSale54$23.3KSEC ↗
Feb 27, 2024VRTXEVP, Global Research and CSOSale4.2K$1.8MSEC ↗
Feb 23, 2024VRTXEVP, Global Research and CSOSale3.0K$1.3MSEC ↗
Feb 21, 2024VRTXEVP, Global Research and CSOSale4.0K$1.7MSEC ↗
Feb 13, 2024VRTXEVP, Global Research and CSOSale3.1K$1.3MSEC ↗
Nov 17, 2023VRTXEVP, Global Research and CSOSale19$7.0KSEC ↗
Aug 11, 2023VRTXEVP, Global Research and CSOSale63$21.8KSEC ↗
Feb 28, 2023VRTXEVP, Global Research and CSOSale4.2K$1.2MSEC ↗
Feb 22, 2023VRTXEVP, Global Research and CSOSale4.0K$1.2MSEC ↗
Feb 16, 2023VRTXEVP, Global Research and CSOSale6.4K$1.9MSEC ↗
Feb 14, 2023VRTXEVP, Global Research and CSOSale4.8K$1.4MSEC ↗
Feb 8, 2023VRTXEVP, Global Research and CSOSale1.3K$399.0KSEC ↗
Nov 17, 2022VRTXEVP, Global Research and CSOSale34$10.5KSEC ↗
Nov 9, 2022VRTXEVP, Global Research and CSOSale1.3K$394.9KSEC ↗
Aug 10, 2022VRTXEVP, Global Research and CSOSale1.3K$381.5KSEC ↗
Jul 21, 2022VRTXEVP, Global Research and CSOSale17.9K$5.2MSEC ↗
Feb 28, 2022VRTXEVP, Global Research and CSOSale7.6K$1.7MSEC ↗

Showing the 25 most recent filings of 71. Screen every filing.

David Altshuler insider trading FAQ

Is David Altshuler buying or selling?

Across 71 SEC Form 4 filings, David Altshuler reported 0 open-market purchases totaling $0 and 71 sales totaling $80.7M — a net selling position of $80.7M.

Which companies does David Altshuler file Form 4s for?

David Altshuler has reported insider transactions at 1 company, most often VERTEX PHARMACEUTICALS INC / MA (VRTX).

How far back does David Altshuler's filing history go?

Trabud holds David Altshuler's SEC Form 4 filings from Jan 17, 2018 – May 19, 2025, sourced directly from SEC EDGAR.

Where does Trabud get David Altshuler's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track David Altshuler and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener